NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyCutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
About This Grant
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Grant Summary
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) is a National Institutes of Health grant providing up to $150K for municipality. Applications are due 2027-08-11 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $150K
2027-08-11
- 1Confirm your organization is eligible for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional): Frequently Asked Questions
Who is eligible for the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) provide?
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) provides up to $150K per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) deadline?
Applications for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) are due 2027-08-11 (open). Because deadlines can change, verify the date with the funder, National Institutes of Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)?
To apply for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.